WEST LAFAYETTE, Ind. — (BUSINESS WIRE) — October 8, 2014 — Officials of the Purdue Office of Technology Commercialization announce the 24 startups that comprise the " Class of 2014." These are companies whose primary technology is based on a licensed Purdue University innovation.
By comparison, Purdue had eight startups in the 2013 fiscal year. In addition, there are over 20 other significant startups created in the 2014 fiscal year that are based on Purdue know-how or student-owned intellectual property not included in the list of new companies.
"Purdue University is internationally recognized as one of the most prolific research institutions in the world, and what we are witnessing is the sheer ingenuity and dedication of the university's outstanding innovators and the support we have received from our surrounding community," said Dan Hasler, president of the Purdue Research Foundation. "With this Startup Class of 2014 we have taken many of the first steps to establish Purdue and the Greater Lafayette area as a hotbed of entrepreneurial opportunity."
Videos or websites about the startups can be viewed by clicking their names:
Animated Dynamics Inc., a life sciences firm providing live-tissue imaging technology to improve biodynamic imaging in healthcare.
Aten Biotherapeutics LLC, a life sciences company developing MRI agents that could make imaging sessions longer and safer.
Battle Ground Technologies LLC, an information technology company working on electronic security.
Bearing Analytics Inc., an industrial technology firm that could predict rotating machinery failure.
Biokorf LLC, a pharmaceutical company creating prefabricated drug dosages that support patient-centric medicine treatments.
BlueVine Graphene Industries Inc., an engineering company developing graphene petal structures for biosensors and energy storage.
CPrecisely Inc., a computer technology firm whose technology could make digital text and images on computer screens easier to see.
Drug Free Therapeutix LLC, a biomedical engineering company that improves customization times for neural stimulation treatments.
Energy Driven Technologies LLC, a nanotechnology company developing surface treatment products to achieve better mechanical properties.
FORSUGO Hi-Cell Inc., a Marrero, Louisiana-based company developing a nuclear detection system for low-cost detectors.
Frontier Additive Manufacturing LLC, a Crawfordsville, Indiana-based company producing 3-D printing at the molecular level for advanced manufacturing.
KinaSense LLC, a life sciences firm developing diagnostic and treatment methods for cancer patients.
Mobile Enerlytics LLC, a software company developing a technology to increase smartphone battery life and reduce energy usage of smartphone apps.
Nano-Meta Technologies Inc., an electrical and computer engineering company developing nanomaterials and improved nanophotonics.
NEMOco LLC, an electrical and computer engineering company doing nanoscale transistor modeling to optimize transistor design prior to fabrication.
Neuro Vigor LLC, a life sciences company developing a technology to reduce symptoms and pain of neurological disease and injury, including MS, neuropathic pain and Parkinson's disease.
Sagamore-Adams Laboratories LLC, a Chicago-based company developing neutron detection systems for use in defense energy, industrial, commercial and residential applications.
SensorHound LLC, a software and services startup developing specialized software and services to improve the reliability and reduce the cost of networked embedded systems.
SPEAK MODalities LLC, a software company offering iPAD applications to help children and families dealing with non-verbal autism improve communications and further develop language skills.
SpeechVive Inc., a company developing a product to help those with Parkinson's disease speak louder and more clearly.
Spero Energy Inc., a company creating specialized chemicals for the flavor and fragrance industry and improving biofuel production.
Biomedical Inc., a San Francisco-based biomedical company developing
tissue scaffold technology to target tissues that could become vascular.